.webp)
Rocket Lab USA D
RKLB
Rocket Lab USA stock forecast 2026–2028What is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
Analysts' average 12-month price target for Rocket Lab USA is 103.08, 73.9% above the current price of 59.28. Their targets range from 58.00 to 132.00.
Of the 15 firms that rated Rocket Lab USA in the past 12 months, 12 rate it buy or strong buy, 3 hold and 0 sell or strong sell (each firm at its latest rating): a Strong buy consensus.
Analysts' 1-year price targets range from 58.00 to 132.00, with an average of 103.08.
| Buy | 12 | |
| Hold | 3 | |
| Sell | 0 |
12-month price target
| Highest target | 132.00 |
| Average target | 103.08 |
| Lowest target | 58.00 |
| Current price | 59.28 |
Rocket Lab USA price target historyWhat is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
Have analysts recently raised or lowered their Rocket Lab USA price target and rating?
How analysts rate Rocket Lab USA, month by monthWhat is the analyst rating? The analyst rating sums up what the analysts covering a stock recommend, from strong buy to strong sell, by the share of them rating it a buy.
12 of 15 firms rate it buy now, against 7 of 11 in December 2025.
Each month: every firm at its latest rating from the 12 months before. Strong buys count as buys, strong sells as sells.
Rocket Lab USA analyst upgrades, downgrades and price targets
The latest rating change came on 27 July 2026, when KGI Securities upgraded Rocket Lab USA from Neutral to Outperform. Its price target is 107.00, from 105.00. The most recent new target came from Piper Sandler on 10 November 2026: 58.00.
| Date | Firm | Rating | Price target | Change | Price then |
|---|---|---|---|---|---|
| 10 Nov 2026 | Piper Sandler Alexander Potter | Reiterated · Neutral | 83.00 → 58.00 | -30.1% | 59.26 |
| 16 Oct 2026 | Needham Ryan Koontz | — | 90.00 → 120.00 | +33.3% | 55.25 |
| 15 Oct 2026 | KeyBanc | Reiterated · Overweight | 135.00 → 100.00 | -25.9% | 59.18 |
| 8 Oct 2026 | Barclays | — | 85.00 | — | 68.40 |
| 11 Sept 2026 | Raymond James Brian Gesuale | — | 80.00 | — | 61.96 |
| 2 Sept 2026 | Berenberg Bank | — | 83.00 | — | 62.54 |
| 11 Aug 2026 | Cantor Fitzgerald Andres Sheppard | Reiterated · Overweight | 85.00 → 122.00 | +43.5% | 78.85 |
| 11 Aug 2026 | Roth Capital | — | 130.00 → 110.00 | -15.4% | 80.04 |
| 27 Jul 2026 | KGI Securities | Upgraded · Neutral → Outperform | 105.00 → 107.00 | +1.9% | 63.91 |
| 15 Jul 2026 | Piper Sandler Alexander Potter | — | 83.00 | — | 76.20 |
| 29 Jun 2026 | Roth Capital Suji Desilva | — | 100.00 → 130.00 | +30.0% | 98.01 |
| 29 Jun 2026 | Craig-Hallum Jeff Van Rhee | — | 98.00 → 120.00 | +22.4% | 98.11 |
| 15 Jun 2026 | KeyBanc Michael Leshock | Upgraded · Sector Weight → Overweight | 75.00 → 135.00 | +80.0% | 102.39 |
| 11 Jun 2026 | KGI Securities | — | 105.00 | — | 105.05 |
| 4 Jun 2026 | Stifel Nicolaus Erik Rasmussen | — | 105.00 → 132.00 | +25.7% | 114.70 |
| 12 May 2026 | Deutsche Bank | Reiterated · Buy | 120.00 | — | 116.17 |
| 8 May 2026 | Craig-Hallum | — | 98.00 | — | 78.58 |
| 20 Apr 2026 | Stifel Nicolaus | Reiterated · Buy | 85.00 → 105.00 | +23.5% | 87.75 |
| 17 Apr 2026 | Roth Capital | Reiterated · Buy | 75.00 → 100.00 | +33.3% | 82.93 |
| 7 Apr 2026 | Citizens | Upgraded · Market Perform → Market Outperform | — | — | — |
| 13 Mar 2026 | Cantor Fitzgerald Andres Sheppard | Reiterated · Overweight | 35.00 → 85.00 | +142.9% | 68.37 |
| 20 Jan 2026 | Goldman Sachs Anthony Valentini | Reiterated · Neutral | 69.00 | — | 96.30 |
| 16 Jan 2026 | Morgan Stanley Kristine Liwag | Upgraded · Equal Weight → Overweight | 105.00 | — | 90.76 |
| 15 Jan 2026 | Keybanc | Downgraded · Overweight → Sector Weight | — | — | — |
| 23 Dec 2025 | Needham Ryan Koontz | Reiterated · Buy | 63.00 → 90.00 | +42.9% | 77.55 |
| 22 Dec 2025 | Stifel Nicolaus | Reiterated · Buy | 75.00 → 85.00 | +13.3% | 70.52 |
| 12 Nov 2025 | Needham Ryan Koontz | Reiterated · Buy | 63.00 | — | 54.98 |
| 11 Nov 2025 | Roth Capital Suji Desilva | — | 75.00 | — | 51.90 |
| 11 Nov 2025 | Stifel Nicolaus Erik Rasmussen | Reiterated · Buy | 31.00 → 75.00 | +141.9% | 51.90 |
Rocket Lab USA EPS and revenue estimatesWhat are estimate revisions? Estimate revisions are the changes analysts make to their EPS and revenue forecasts for the years ahead. They show whether expectations are rising or falling.
Revenue
EPS
Does Rocket Lab USA beat earnings estimates?What is an earnings surprise? An earnings surprise is how far a company's reported EPS or revenue came above or below the analysts' average estimate, in percent.
On average, analysts' EPS estimate was 31.8% off the result, either way, and their revenue estimate 2.8%, over the last 12 quarters.
- EPS beats
- 8 / 21
- Revenue beats
- 17 / 21
- Average EPS surprise, last 12What is an earnings surprise? An earnings surprise is how far a company's reported EPS or revenue came above or below the analysts' average estimate, in percent.
- +7.6%
- Since
- November 2021
| Quarter | Report date | EPS estimate | Reported EPS | Surprise | Revenue estimate | Reported revenue | Surprise |
|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 9 Nov 2026 | -0.07 | -0.12 | -79.5% | 257.21M | 267.83M | +4.1% |
| Q2 FY2026 | 10 Aug 2026 | -0.06 | -0.08 | -37.2% | 231.62M | 234.07M | +1.1% |
| Q1 FY2026 | 7 May 2026 | -0.07 | -0.02 | +70.2% | 189.65M | 200.35M | +5.6% |
| Q4 FY2025 | 26 Feb 2026 | -0.10 | -0.09 | +8.9% | 176.83M | 179.65M | +1.6% |
| Q3 FY2025 | 10 Nov 2025 | -0.10 | 0.01 | +110.1% | 151.80M | 155.00M | +2.1% |
| Q2 FY2025 | 7 Aug 2025 | -0.10 | -0.10 | -5.0% | 135.41M | 144.50M | +6.7% |
| Q1 FY2025 | 8 May 2025 | -0.11 | -0.12 | -12.6% | 121.40M | 122.57M | +1.0% |
| Q4 FY2024 | 27 Feb 2025 | -0.09 | -0.10 | -11.1% | 130.57M | 132.39M | +1.4% |
| Q3 FY2024 | 12 Nov 2024 | -0.11 | -0.10 | +9.1% | 102.28M | 104.81M | +2.5% |
| Q2 FY2024 | 8 Aug 2024 | -0.10 | -0.08 | +20.0% | 105.47M | 106.25M | +0.7% |
| Q1 FY2024 | 6 May 2024 | -0.11 | -0.09 | +18.2% | 94.98M | 92.77M | -2.3% |
| Q4 FY2023 | 27 Feb 2024 | -0.10 | -0.10 | 0.0% | 62.90M | 59.99M | -4.6% |
Rocket Lab USA stock price 2026–2028: scenariosHow are the stock price scenarios calculated? Bear, base and bull prices for the years ahead: the analysts' EPS estimates times the lowest, average and highest P/E of the stock today and at its last five year ends, or of its peers.
There are no price scenarios for Rocket Lab USA: its P/E has been above 60, or from losses, too often in the last five years to price its earnings at, and similar companies' P/Es put its value too far from its price to stand in. The earnings analysts expect are in the estimates above.
Most undervalued US stocksHow does Arincen work out a stock's fair value? Fair value is our estimate of a share's price at the P/E the company usually trades at, with a low to high range around it.
| Stock | Price | Fair value | Upside |
|---|---|---|---|
| 97.350 | 194.84146Price 97.35244 | +100.1% | |
| 119.980 | 236.63177Price 119.98296 | +97.2% | |
| 197.050 | 384.58163Price 197.052,644 | +95.2% | |
| 157.530 | 305.52161Price 157.53396 | +93.9% | |
| 43.270 | 82.9546Price 43.27165 | +91.7% | |
| 214.470 | 405.52304Price 214.47507 | +89.1% | |
| 163.700 | 308.95212Price 163.70442 | +88.7% |
Furthest below the fair value on each stock's page, updated every day.